Covista Inc.
NYSECVSA enters its Q3 FY2026 earnings call on May 1 carrying two unusually clear and opposing signals: a lead independent director who put nearly $3.8 million of his own money into the stock over six weeks, and a short position that just posted its biggest weekly build in months. The insider signal is the harder one to ignore. Lead Independent Director Michael Malafronte made three…
Snapshot as of 10 May 2026
CVSA enters its Q3 FY2026 earnings call on May 1 carrying two unusually clear and opposing signals: a lead independent director who put nearly $3.8 million of his own money into the stock over six weeks, and a short…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CVSA — free to start on ORTEX.
Sign up for free →Open CVSA on ORTEX